BIIB vs SFNC · P/E 21, rev $9.89B vs rev $1.24B
Biogen Inc (BIIB) versus Simmons First National Corporation (SFNC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Simmons First National Corporation (SFNC) is a banks - regional company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported SFNC revenue for 2025-12-31 was $1.24B. Net income was -$397.6M. SFNC currently screens at market cap $3.15B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. SFNC currently screens at market cap $3.15B.
Not investment advice. Open the BIIB and SFNC stock pages for the full models.
Not investment advice.